acebutolol has been researched along with metoprolol in 84 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 37 (44.05) | 18.7374 |
1990's | 13 (15.48) | 18.2507 |
2000's | 21 (25.00) | 29.6817 |
2010's | 10 (11.90) | 24.3611 |
2020's | 3 (3.57) | 2.80 |
Authors | Studies |
---|---|
Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H | 1 |
Carrupt, PA; Gaillard, P; Schambel, P; Testa, B | 1 |
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
Baker, JG | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Akamatsu, M; Fujikawa, M; Nakao, K; Shimizu, R | 1 |
Abraham, MH; Acree, WE; Ibrahim, A | 1 |
Carrupt, PA; Guillarme, D; Henchoz, Y; Rudaz, S; Veuthey, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahman, M; Holmén, AG; Wan, H | 1 |
Bard, B; Carrupt, PA; Martel, S | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Akamatsu, M | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bucki, A; Głuch-Lutwin, M; Jaromin, A; Jastrzębska-Więsek, M; Kołaczkowski, M; Mordyl, B; Partyka, A; Siwek, A; Walczak, M; Wesołowska, A; Zagórska, A | 1 |
Chubb, IW; Raine, AE | 1 |
Gooren, L; Harms, HH; Hesse, C; Spoelstra, AJ; Verschoor, L | 1 |
Kiechel, JR; Meier, J | 1 |
Tannenbaum, H | 1 |
Littler, WA; Stallard, TJ; Watson, RD | 2 |
Godtlibsen, OB; Kayed, K | 1 |
Newman, RJ | 1 |
Hayashi, T; Ichinohe, T; Ikeda, S; Ikeda, Y; Kawaguchi, K; Kotake, C; Koya, Y; Onaka, H; Seo, T; Suyama, K | 1 |
Abrignani, MG; Corda, M; Cosentino, F; Liquori, M; Novo, S; Pinto, A; Strano, A | 1 |
Behr, U; Franz, IW; Ketelhut, R; Tönnesmann, U | 2 |
Beudin, P; Ducher, JL; Gibert, J; Kantelip, JP; Lauxerois, M; Pechadre, JC; Sabot, C; Trolese, JF | 1 |
Palkama, A; Raij, K; Uusitalo, H; Uusitalo, R | 1 |
Jelnes, R; Svendsen, TL; Tønnesen, KH | 2 |
Jackson, PR; Lewis, RV; Ramsay, LE | 1 |
Fishbein, L; Jackson, CD | 1 |
Tattersfield, AE; Thomas, MS | 1 |
Antonaccio, MJ; DeForrest, JM; High, J; Sybertz, E | 1 |
Czarnecka, D; Kawecka-Jaszcz, K; Kocemba, J; Skoczeń, M; Wojciechowska, M | 1 |
Carlsen, JE; Heebøll-Nielsen, NC | 1 |
al-Gohary, O; Lyal, J; Murray, JB | 1 |
Höltermann, FP; Strasser, R; von Mengden, HJ | 1 |
Coumel, P; Delhotal-Landes, B; Escoubet, B; Gourmel, B; Leclercq, JF; Maison-Blanche, P; Poirier, JM | 1 |
Boucher, M; Duchene-Marullaz, P | 1 |
Borer, JS; Moses, JW | 1 |
Greefhorst, AP; van Herwaarden, CL | 2 |
Brotelle, R; Colot, M; de Clavière, M; Heyndrickx, JP | 1 |
Hatori, Y; Horii, M; Nakamura, Y; Nemoto, E; Otsuka, K; Sakai, T; Tsukiyama, H; Yamamoto, Y; Yamato, T; Yoshii, Y | 1 |
Eisalo, A; Mänttäri, M | 1 |
Auzépy, P; Boukara, N; Giudicelli, JF; Richard, C | 1 |
Franz, IW; Gubba, A; Koch, G; Lohmann, FW | 1 |
Jack, DB; Kendall, MJ; Quarterman, CP; Smith, SR; Zaman, R | 1 |
Drayer, JI; Weber, MA | 1 |
Jack, DB; Quarterman, CP; Wilkins, M | 1 |
Jack, DB | 1 |
Franz, IW; Koch, G; Lohmann, FW | 1 |
Górecki, A; Ignatowska-Switalska, H; Januszewicz, A; Kochanowski, J; Lapiński, M; Opolski, G; Stolarz, P; Słomka, K; Wocial, B | 1 |
Ambrosio, G; Chiariello, M; Chiariello, P; Napoli, C; Palumbo, G | 1 |
Kuralay, E; Oztürk, OY; Süer, H; Tatar, H; Yorulmaz, FM | 1 |
Klug, S; Merker, HJ; Neubert, D; Schwabe, R; Thiel, R | 1 |
Iisalo, E; Kaila, T | 1 |
Murakami, H; Nishimura, M; Urabe, K | 1 |
Caldwell, GW; Evangelisto, M; Masucci, JA; White, R | 1 |
Caldwell, GW; Demarest, K; Easlick, SM; Gunnet, J; Masucci, JA | 1 |
Black, M; Cayenne, S; Cohen, TJ; Doolittle, S; Ibrahim, B; Quan, W | 1 |
Foster, R; Lewanczuk, R; Mostafavi, S | 1 |
Schröder, H | 1 |
Abrahamowicz, M; Austin, PC; Eisenberg, MJ; Humphries, K; Pilote, L; Richard, H; Rinfret, S; Tu, J | 1 |
Arima, Y; Hasegawa, C; Izawa, H; Kumazawa, T; Lee, XP; Sato, K; Umezawa, H | 1 |
Armaković, S; Armaković, SJ; Setrajčić, IJ; Setrajčić, JP | 1 |
Abdel-Rehim, M; Abuzooda, T; Amini, A | 1 |
Abdel-Rehim, M; Dutta, J; Hadjmohammadi, MR; Karimiyan, H; Kunjali, KL; Moein, MM | 1 |
Ansorge, M; Dovhunová, M; Galić, N; Habinovec, I; Pocrnić, M; Tesařová, E | 1 |
Chen, YW; Chou, AK | 1 |
6 review(s) available for acebutolol and metoprolol
Article | Year |
---|---|
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1988 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Comparative pharmacokinetics of beta-blockers].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Half-Life; Humans; Metoprolol; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol; Timolol | 1978 |
[Long-term utilization of beta-blockers in arterial hypertension].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Blood Pressure; Coronary Disease; Drug Tolerance; Heart Rate; Humans; Hypertension; Metoprolol; Pindolol; Practolol; Time Factors | 1978 |
A toxicological review of beta-adrenergic blockers.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Cocarcinogenesis; Ethanolamines; Female; Kinetics; Labetalol; Lethal Dose 50; Male; Metoprolol; Mice; Mutagens; Nadolol; Neoplasms, Experimental; Oxprenolol; Pindolol; Practolol; Propanolamines; Propranolol; Rats; Sotalol; Timolol | 1986 |
Beta-adrenergic antagonists in the treatment of patients with heart disease.
Topics: Acebutolol; Adrenergic beta-Agonists; Alprenolol; Animals; Arrhythmias, Cardiac; Bronchial Spasm; Cardiomyopathy, Hypertrophic; Coronary Disease; Female; Heart Diseases; Heart Failure; Humans; Hypertension; Metoprolol; Mitral Valve Prolapse; Mitral Valve Stenosis; Nadolol; Nervous System Diseases; Pindolol; Pregnancy; Pregnancy Complications, Cardiovascular; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Structure-Activity Relationship; Timolol | 1981 |
20 trial(s) available for acebutolol and metoprolol
Article | Year |
---|---|
Effects of the beta-adrenoceptor antagonists acebutolol and metoprolol on sleep pattern in normal subjects.
Topics: Acebutolol; Adult; Electroencephalography; Female; Humans; Male; Mental Recall; Metoprolol; Placebos; Propanolamines; Sleep; Task Performance and Analysis; Time Factors | 1977 |
Comparison of the antilipolytic effect of metoprolol, acebutolol, and propranolol in man.
Topics: Acebutolol; Adult; Fatty Acids, Nonesterified; Humans; Insulin; Lipid Metabolism; Male; Metoprolol; Propanolamines; Propranolol | 1977 |
Regression of structural vascular changes after chronic treatment in hypertensives.
Topics: Acebutolol; Adult; Aged; Blood Pressure; Captopril; Female; Hemodynamics; Humans; Hypertension; Labetalol; Leg; Male; Metoprolol; Middle Aged; Regional Blood Flow; Vascular Resistance | 1991 |
[Regression of left ventricular hypertrophy in hypertensive patients under long-term therapy with antihypertensive agents].
Topics: Acebutolol; Adult; Antihypertensive Agents; Atenolol; Cardiomegaly; Female; Gallopamil; Humans; Hypertension; Male; Metoprolol; Middle Aged; Nifedipine; Time Factors | 1990 |
[Regression of left heart hypertrophy in hypertensive patients as a result of antihypertensive therapy].
Topics: Acebutolol; Adult; Antihypertensive Agents; Atenolol; Cardiac Output; Cardiac Volume; Cardiomegaly; Drug Therapy, Combination; Echocardiography; Enalapril; Female; Gallopamil; Humans; Hydrochlorothiazide; Hypertension; Male; Metoprolol; Middle Aged; Nifedipine | 1989 |
[Central effects of five beta-adrenergic receptor blockers in healthy volunteers: a quantitative EEG study].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Brain; Carteolol; Electroencephalography; Humans; Male; Metoprolol; Monitoring, Physiologic; Pindolol; Sotalol | 1989 |
Is adrenergic betareceptor blockade contraindicated in patients with intermittent claudication?
Topics: Acebutolol; Adrenergic beta-Antagonists; Aged; Blood Pressure; Female; Humans; Intermittent Claudication; Locomotion; Male; Metoprolol; Middle Aged | 1985 |
Comparison of beta-adrenoceptor selectivity of acebutolol and its metabolite diacetolol with metoprolol and propranolol in normal man.
Topics: Acebutolol; Adrenergic beta-Antagonists; Airway Resistance; Dose-Response Relationship, Drug; Heart Rate; Humans; Isoproterenol; Metoprolol; Physical Exertion; Propranolol; Receptors, Adrenergic, beta | 1986 |
[Comparative effects of metoprolol and acebutolol in primary arterial hypertension].
Topics: Acebutolol; Adult; Aged; Blood Pressure; Clinical Trials as Topic; Female; Humans; Hypertension; Male; Metoprolol; Middle Aged | 1988 |
[A randomized comparison between acebutolol and metoprolol in 215 patients with hypertension. Significance of the self-stimulating effect and awareness of the occurrence of adverse effects].
Topics: Acebutolol; Adolescent; Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension; Male; Metoprolol; Middle Aged; Random Allocation | 1988 |
The effects of acebutolol and metoprolol on walking distances and distal blood pressure in hypertensive patients with intermittent claudication.
Topics: Acebutolol; Aged; Blood Pressure; Clinical Trials as Topic; Female; Hemodynamics; Humans; Hypertension; Intermittent Claudication; Locomotion; Male; Metoprolol; Middle Aged; Random Allocation | 1986 |
Comparison of four beta-blockers as assessed by 24-hour ECG recording.
Topics: Acebutolol; Administration, Oral; Adult; Blood Pressure; Dose-Response Relationship, Drug; Drug Evaluation; Electrocardiography; Female; Heart Rate; Humans; Male; Metoprolol; Middle Aged; Nadolol; Propanolamines; Propranolol; Random Allocation | 1986 |
Comparative study of the ventilatory effects of three beta 1-selective blocking agents in asthmatic patients.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Asthma; Atenolol; Bronchi; Clinical Trials as Topic; Heart Rate; Humans; Male; Metoprolol; Pulmonary Ventilation; Respiration; Terbutaline; Vital Capacity | 1981 |
A comparison of two cardioselective beta-blockers with different ancillary properties in the treatment of hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension; Male; Metoprolol; Middle Aged; Propanolamines | 1982 |
beta-adrenoceptor blockade and physical activity: cardiovascular and metabolic aspects.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Blood Glucose; Catecholamines; Hemodynamics; Humans; Hypertension; Lactates; Lactic Acid; Lipolysis; Male; Metoprolol; Oxygen Consumption; Physical Exertion; Pindolol; Pituitary Hormones, Anterior; Respiration | 1983 |
Single-agent and combination therapy of essential hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aldosterone; Blood Pressure; Diuretics; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Male; Metoprolol; Middle Aged; Propranolol; Renin-Angiotensin System | 1984 |
Ventilatory and haemodynamic effects of terbutaline infusion during beta 1-selective blockade with metoprolol and acebutolol in asthmatic patients.
Topics: Acebutolol; Adult; Asthma; Clinical Trials as Topic; Double-Blind Method; Female; Forced Expiratory Volume; Hemodynamics; Humans; Male; Metoprolol; Middle Aged; Peak Expiratory Flow Rate; Propanolamines; Respiration; Terbutaline | 1982 |
Effects of short-term and long-term treatment with cardio-selective and non-selective beta-receptor blockade on carbohydrate and lipid metabolism and on plasma catecholamines at rest and during exercise.
Topics: Acebutolol; Adult; Blood Glucose; Dopamine; Epinephrine; Humans; Hypertension; Lipids; Long-Term Care; Metoprolol; Pindolol; Propanolamines | 1981 |
Beneficial effects of beta-adrenergic blockade in coronary artery surgery: clinical research.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Cardiotonic Agents; Coronary Artery Bypass; Coronary Disease; Female; Heart Rate; Humans; Hypertension; Male; Metoprolol; Middle Aged; Postoperative Complications; Premedication | 1993 |
Selectivity of acebutolol, atenolol, and metoprolol in healthy volunteers estimated by the extent the drugs occupy beta 2-receptors in the circulating plasma.
Topics: Acebutolol; Administration, Oral; Adult; Animals; Atenolol; Double-Blind Method; Humans; Male; Metoprolol; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Time Factors | 1993 |
58 other study(ies) available for acebutolol and metoprolol
Article | Year |
---|---|
Binding of arylpiperazines, (aryloxy)propanolamines, and tetrahydropyridylindoles to the 5-HT1A receptor: contribution of the molecular lipophilicity potential to three-dimensional quantitative structure-affinity relationship models.
Topics: Indoles; Ligands; Models, Molecular; Molecular Conformation; Molecular Structure; Piperazines; Propanolamines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Structure-Activity Relationship; Tetrahydronaphthalenes | 1996 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Algorithms; Animals; Cell Line; CHO Cells; Cricetinae; Dioxoles; Humans; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3 | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
QSAR study on permeability of hydrophobic compounds with artificial membranes.
Topics: Biological Transport; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrophobic and Hydrophilic Interactions; Membranes, Artificial; Permeability; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship | 2007 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
High-throughput log P determination by ultraperformance liquid chromatography: a convenient tool for medicinal chemists.
Topics: Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Chromatography, Liquid; Mathematics; Pharmaceutical Preparations; Software | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Lipophilicity of basic drugs measured by hydrophilic interaction chromatography.
Topics: Chemistry, Pharmaceutical; Chromatography; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Pharmaceutical Preparations; Solubility; Technology, Pharmaceutical | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Importance of physicochemical properties for the design of new pesticides.
Topics: Anabasine; Animals; Biological Availability; Cell Membrane Permeability; Chemical Phenomena; Drug Design; Humans; Imidazoles; Insecticides; Neonicotinoids; Nitro Compounds; Pesticides; Quantitative Structure-Activity Relationship; Receptors, Nicotinic | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Design, synthesis, and behavioral evaluation of dual-acting compounds as phosphodiesterase type 10A (PDE10A) inhibitors and serotonin ligands targeting neuropsychiatric symptoms in dementia.
Topics: Animals; Antipsychotic Agents; Dementia; Humans; Ligands; Mice; Phosphoric Diester Hydrolases; Serotonin | 2022 |
Long term beta-adrenergic blockade reduces tyrosine hydroxylase and dopamine beta-hydroxylase activities in sympathetic ganglia.
Topics: Acebutolol; Adrenergic beta-Antagonists; Animals; Blood Pressure; Dopamine beta-Hydroxylase; Ganglia, Autonomic; Metoprolol; Neural Pathways; Practolol; Propranolol; Rabbits; Time Factors; Tyrosine 3-Monooxygenase | 1977 |
Blockade of isoprenaline-induced changes in plasma free fatty acids, immunoreactive insulin levels and plasma renin activity in healthy human subjects, by propranolol, pindolol, practolol, atenolol, metoprolol and acebutolol.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Fatty Acids, Nonesterified; Heart Rate; Humans; Insulin; Isoproterenol; Male; Metoprolol; Pindolol; Practolol; Propranolol; Renin | 1978 |
Effects of beta-adrenoreceptor antagonists on sino-aortic baroreflex sensitivity and blood pressure in hypertensive man.
Topics: Acebutolol; Adolescent; Adrenergic beta-Agonists; Adult; Aging; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Male; Metoprolol; Middle Aged; Physical Exertion; Pressoreceptors; Propranolol; Sinoatrial Node; Time Factors | 1979 |
Influence of once-daily administration of beta-adrenoceptor antagonists on arterial pressure and its variability.
Topics: Acebutolol; Activities of Daily Living; Adolescent; Adult; Bed Rest; Blood Pressure; Circadian Rhythm; Diastole; Female; Humans; Hypertension; Male; Metoprolol; Middle Aged; Physical Exertion; Propanolamines; Propranolol; Sleep; Systole | 1979 |
[The effect of acebutolol and metoprolol on noninvasive ambulatory blood pressure monitoring system in essential hypertension].
Topics: Acebutolol; Adult; Aged; Blood Pressure; Blood Pressure Monitors; Circadian Rhythm; Female; Humans; Hypertension; Male; Metoprolol; Middle Aged | 1992 |
Comparison of the effects of adrenergic agonists and alpha-, beta 1-, beta 2-antagonists on the intraocular pressure and adenylate cyclase activity in the ciliary processes of the rabbit.
Topics: Acebutolol; Adenylyl Cyclases; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Ciliary Body; Intraocular Pressure; Isoproterenol; Labetalol; Metoprolol; Rats; Timolol; Water | 1985 |
Side-effects of beta-blockers assessed using visual analogue scales.
Topics: Acebutolol; Adrenergic beta-Antagonists; Analysis of Variance; Atenolol; Dreams; Fatigue; Humans; Hypertension; Metoprolol; Oxprenolol; Propranolol | 1985 |
Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
Topics: Acebutolol; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Blood Pressure; Decerebrate State; Heart; Heart Rate; Hypertension; Isoproterenol; Levobunolol; Male; Metoprolol; Oxprenolol; Propranolol; Rats; Rats, Inbred SHR; Renin; Sympathetic Nervous System; Sympathomimetics; Time Factors | 1986 |
Adsorption of antihypertensives by suspensoids. Part 2. The adsorption of acebutolol, metoprolol, nadolol, oxprenolol, and timolol by attapulgite, charcoal, kaolin and magnesium trisilicate.
Topics: Acebutolol; Adsorption; Antihypertensive Agents; Charcoal; Kaolin; Magnesium; Magnesium Compounds; Magnesium Silicates; Metoprolol; Nadolol; Oxprenolol; Silicic Acid; Silicon; Silicon Compounds; Timolol | 1988 |
[Echocardiography studies of the relevance and intrinsic activity of beta blockers in the human].
Topics: Acebutolol; Adult; Echocardiography; Hemodynamics; Humans; Metoprolol; Myocardial Contraction | 1986 |
Acebutolol, metoprolol and propranolol in conscious dogs with chronic heart-block: chronotropic effects and relation between depression of ventricular activity and beta-adrenoceptor blocking potency.
Topics: Acebutolol; Adrenergic beta-Antagonists; Animals; Blood Pressure; Depression, Chemical; Dogs; Female; Heart Block; Heart Rate; Male; Metoprolol; Propranolol | 1980 |
Variability in the preventive action of the B-blockers on genetic hypertension in the rat.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Blood Pressure; Dose-Response Relationship, Drug; Hypertension; Male; Metoprolol; Oxprenolol; Pindolol; Practolol; Propranolol; Rats; Rats, Inbred Strains; Species Specificity; Time Factors | 1980 |
Possible significance of the pharmacological differentiation of beta-blocking agents in hemodynamic effects in essential hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Atenolol; Carteolol; Hemodynamics; Humans; Hypertension; Metoprolol; Oxprenolol; Propranolol | 1983 |
[Acute poisoning caused by beta blockers in the adult. Apropos of 7 cases].
Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Adult; Alcohol Drinking; Bradycardia; Coma; Dose-Response Relationship, Drug; Female; Humans; Male; Metoprolol; Middle Aged; Oxprenolol; Propranolol; Seizures | 1983 |
Beta-adrenoceptor blocker pharmacokinetics and the oral contraceptive pill.
Topics: Acebutolol; Adrenergic beta-Antagonists; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Drug Interactions; Female; Humans; Kinetics; Metoprolol; Oxprenolol; Propranolol; Time Factors | 1984 |
Lack of evidence for polymorphism in metoprolol metabolism.
Topics: Acebutolol; Adult; Biotransformation; Half-Life; Humans; Metoprolol; Polymorphism, Genetic | 1983 |
Statistical analysis of polymorphic drug metabolism data using the Rosin Rammler Sperling Weibull distribution.
Topics: Acebutolol; Africa; Debrisoquin; Humans; Isoniazid; Metoprolol; Polymorphism, Genetic; Sparteine; Statistics as Topic | 1983 |
Elevated plasma atrial natriuretic peptide concentrations in hypertensive patients with acute myocardial infarction.
Topics: Acebutolol; Adult; Aged; Atrial Natriuretic Factor; Blood Pressure; Cardiac Output, Low; Creatine Kinase; Creatinine; Echocardiography; Female; Furosemide; Heart Atria; Heart Ventricles; Humans; Hypertension; Isoenzymes; Male; Metoprolol; Middle Aged; Myocardial Infarction; Nifedipine; Potassium; Sodium | 1995 |
[Protection by blockers against human low density lipoprotein peroxidation induced by oxygen free radicals].
Topics: Acebutolol; Adrenergic beta-Antagonists; Free Radicals; Humans; In Vitro Techniques; Lipid Peroxidation; Lipoproteins, LDL; Malondialdehyde; Metoprolol; Propranolol | 1994 |
Toxicity of beta-blockers in a rat whole embryo culture: concentration-response relationships and tissue concentrations.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Dose-Response Relationship, Drug; Embryo, Mammalian; Embryonic and Fetal Development; In Vitro Techniques; Metoprolol; Pindolol; Propranolol; Rats; Rats, Wistar | 1994 |
Relation between dynamic midventricular obstruction and unexplained chest pain in patients with normal echocardiograms at rest.
Topics: Acebutolol; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angina Pectoris; Atenolol; Dobutamine; Echocardiography, Doppler, Color; Female; Humans; Male; Metoprolol; Middle Aged; Rest; Ventricular Outflow Obstruction | 1996 |
Evaluation of the immobilized artificial membrane phosphatidylcholine. Drug discovery column for high-performance liquid chromatographic screening of drug-membrane interactions.
Topics: Acebutolol; Acetonitriles; Adrenergic beta-Antagonists; Alprenolol; Aniline Compounds; Atenolol; Chromatography, High Pressure Liquid; Hydrogen-Ion Concentration; Membranes, Artificial; Metoprolol; Models, Chemical; Osmolar Concentration; Oxprenolol; Phosphatidylcholines; Pindolol; Propranolol; Reproducibility of Results; Timolol | 1998 |
In vitro permeability of eight beta-blockers through Caco-2 monolayers utilizing liquid chromatography/electrospray ionization mass spectrometry.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Atenolol; Biological Availability; Caco-2 Cells; Cell Membrane Permeability; Chromatography, Liquid; Epithelial Cells; Humans; Intestinal Absorption; Intestinal Mucosa; Mass Spectrometry; Metoprolol; Molecular Structure; Oxprenolol; Pindolol; Propranolol; Research Design; Timolol | 1998 |
The effects of intrinsic sympathomimetic activity on beta-blocker efficacy for treatment of neurocardiogenic syncope.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Female; Humans; Male; Metoprolol; Middle Aged; Pindolol; Retrospective Studies; Sympathomimetics; Syncope, Vasovagal; Tilt-Table Test | 1999 |
Influence of acebutolol and metoprolol on cardiac output and regional blood flow in rats.
Topics: Acebutolol; Adrenergic beta-Antagonists; Animals; Cardiac Output; Coronary Vessels; Kidney; Liver; Male; Metoprolol; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Spleen; Stomach; Sympathetic Nervous System; Sympathomimetics | 2000 |
[Antihypertensive therapy with left cardiac insufficiency].
Topics: Acebutolol; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diuretics; Heart Failure; Heart Function Tests; Humans; Hypertension; Male; Metoprolol; Middle Aged; Thiazides; Ventricular Dysfunction, Left | 2005 |
A population-based analysis of the class effect of beta-blockers after myocardial infarction.
Topics: Acebutolol; Adrenergic beta-Antagonists; Aged; Atenolol; Female; Humans; Male; Metoprolol; Myocardial Infarction | 2007 |
Simultaneous determination of beta-blockers in human plasma using liquid chromatography-tandem mass spectrometry.
Topics: Acebutolol; Adrenergic beta-Antagonists; Chromatography, Liquid; Humans; Labetalol; Linear Models; Metoprolol; Pindolol; Propranolol; Sensitivity and Specificity; Tandem Mass Spectrometry | 2008 |
Active components of frequently used β-blockers from the aspect of computational study.
Topics: Acebutolol; Adrenergic beta-Antagonists; Atenolol; Computer Simulation; Hardness; Humans; Hydrocarbons, Aromatic; Magnetic Resonance Spectroscopy; Metoprolol; Models, Molecular; Molecular Conformation; Static Electricity | 2012 |
Graphite-based microextraction by packed sorbent for online extraction of β-blockers from human plasma samples.
Topics: Acebutolol; Adrenergic beta-Antagonists; Chromatography, Liquid; Graphite; Humans; Limit of Detection; Linear Models; Metoprolol; Reproducibility of Results; Solid Phase Microextraction | 2015 |
Graphene Oxide/Polyethylene Glycol-Stick for Thin Film Microextraction of β-Blockers from Human Oral Fluid by Liquid Chromatography-Tandem Mass Spectrometry.
Topics: Acebutolol; Adrenergic beta-Antagonists; Body Fluids; Chromatography, Liquid; Graphite; Humans; Limit of Detection; Metoprolol; Mouth; Nanocomposites; Polyethylene Glycols; Solid Phase Microextraction; Tandem Mass Spectrometry | 2019 |
Chiral separation of beta-blockers by high-performance liquid chromatography and determination of bisoprolol enantiomers in surface waters.
Topics: Acebutolol; Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Chromatography, High Pressure Liquid; Labetalol; Metoprolol; Water | 2020 |
Beta-blocker carteolol and oxprenolol produce cutaneous analgesia in response to needle pinpricks in the rat.
Topics: Acebutolol; Analgesia; Anesthetics, Local; Animals; Bupivacaine; Butoxamine; Carteolol; Dose-Response Relationship, Drug; Epinephrine; Metoprolol; Oxprenolol; Pain; Rats; Rats, Sprague-Dawley | 2023 |